Asahi Kasei Pharma Corporation v. Endo Ventures Limited et al

Filing 134

ORDER: It is hereby ORDERED that by September 17, 2021, the parties shall submit a joint status letter. (As further set forth in this Order.) (Signed by Judge Lorna G. Schofield on 9/7/2021) (cf)

Case 1:19-cv-09060-LGS-SN Document 134 Filed 09/07/21 Page 1 of 1

UNITED STATES DISTRICT COURT
SOUTHERN DISTRICT OF NEW YORK
--------------------------------------------------------------X
ASAHI KASEI PHARMA CORPORATION,
:
:
:
Plaintiff,
:
:
-against:
:
:
ENDO VENTURES LIMITED, ENDO
PHARMACEUTICALS INC., AUXILIUM
:
PHARMACEUTICALS, LCC, AND JUBILANT :
HOLLISTERSTIER LCC,
:
Defendants. :
------------------------------------------------------------- X

19 Civ. 9060 (LGS)
ORDER

LORNA G. SCHOFIELD, District Judge:
WHEREAS, the First Amended Case Management Plan (Dkt. No. 75), dated June 22,
2020, requires the parties to submit a joint status letter every 45 days, and the most recent status
letter was due on September 5, 2021.
WHEREAS, the parties have not submitted a joint status letter and a settlement
conference is scheduled for September 15, 2021. It is hereby
ORDERED that by September 17, 2021, the parties shall submit a joint status letter.

Dated: September 7, 2021
New York, New York